What is ALS Phase 1 Study NP001?

Category: Others

false

See also: Clinical Trial

NCT01091142 is a completed single-ascending-dose safety and tolerability study of NP001 in subjects with Amyotrophic Lateral Sclerosis (ALS). Other study name is NP001 Single Dose - ALS.

Why patients stopped taking ALS Phase 1 Study NP001

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped using ALS Phase 1 Study NP001

Duration

Stopped using ALS Phase 1 Study NP001

Duration Patients
Less than 1 month 1
Last updated:
There are no evaluations for ALS Phase 1 Study NP001.